134 related articles for article (PubMed ID: 1709455)
1. [Cytotoxic effector mechanism and genetic control of non-immunized hybrid resistance to mouse T cell lymphoma transplanted outside and inside the brain].
Yamasaki T; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Neurol Med Chir (Tokyo); 1990; 30(11 Spec No):800-5. PubMed ID: 1709455
[TBL] [Abstract][Full Text] [Related]
2. [Experimental analysis of anti-tumor cytotoxic mechanism for hybrid resistance to mouse neuroblastoma].
Yamasaki T; Moritake K; Kikuchi H; Kärre K; Ljunggren HG; Klein G
No Shinkei Geka; 1990 Nov; 18(11):1015-22. PubMed ID: 2247194
[TBL] [Abstract][Full Text] [Related]
3. Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism.
Grönberg A; Klein GO; Kärre K; Kiessling R; Klein G
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):183-90. PubMed ID: 7201394
[TBL] [Abstract][Full Text] [Related]
4. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
5. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
6. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
Kumar V; Luevano E; Bennett M
J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
[TBL] [Abstract][Full Text] [Related]
7. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
8. Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression.
Yamasaki T; Akiyama Y; Fukuda M; Kimura Y; Moritake K; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Int J Cancer; 1996 Jul; 67(3):365-71. PubMed ID: 8707410
[TBL] [Abstract][Full Text] [Related]
9. Thymus independence of hybrid resistance against a panel of T-cell lymphomas of H-2b origin.
Klein GO; Kärre K; Kiessling R; Klein G
Int J Cancer; 1982 Nov; 30(5):659-62. PubMed ID: 6984022
[TBL] [Abstract][Full Text] [Related]
10. Immune reactivity of the tumor-resistant X/Gf mouse.
Nahas F; Segev Y; Gershon H
Int J Cancer; 1984 Aug; 34(2):237-44. PubMed ID: 6236154
[TBL] [Abstract][Full Text] [Related]
11. Defective cytotoxic T-cell generation in Moloney murine sarcoma virus-infected A/Sn mice.
Becker S; Klein E
J Natl Cancer Inst; 1980 Oct; 65(4):811-6. PubMed ID: 6968372
[TBL] [Abstract][Full Text] [Related]
12. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
13. Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.
Daley JP; Nakamura I
J Exp Med; 1984 Apr; 159(4):1132-48. PubMed ID: 6368735
[TBL] [Abstract][Full Text] [Related]
14. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies on natural resistance to Moloney lymphoma (YAC) isografts. I. Introduction of a non-H-2-linked resistance gene on strain A/Sn background.
Ahrlund-Richter L; Klein G; Klein E
Immunogenetics; 1983; 18(3):221-7. PubMed ID: 6618531
[TBL] [Abstract][Full Text] [Related]
16. Resistance to growth of the Moloney lymphoma YAC in semi-syngeneic graft recipients.
Ahrlund-Richter L; Klein E
Int J Cancer; 1988 Jan; 41(1):123-6. PubMed ID: 3335415
[TBL] [Abstract][Full Text] [Related]
17. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
Kärre K; Klein GO; Kiessling R; Klein G
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
[TBL] [Abstract][Full Text] [Related]
19. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.
Cretney E; Degli-Esposti MA; Densley EH; Farrell HE; Davis-Poynter NJ; Smyth MJ
J Exp Med; 1999 Aug; 190(3):435-44. PubMed ID: 10430631
[TBL] [Abstract][Full Text] [Related]
20. Effects of non-MHC background genes on the induction of CD4+ T cells that prevent rejection of a highly immunogenic tumor, FBL-3.
Morioka A; Iwashiro M; Matsubayashi Y; Teramura Y; Kuribayashi K
Int Immunol; 1994 Jun; 6(6):839-46. PubMed ID: 7916205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
